Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pronova BioPharma Norge and Teva Pharmaceuticals USA have jointly decided to terminate the patent litigation case in the US District Court for the District of Delaware.
Subscribe to our email newsletter
The lawsuit covers Pronova BioPharma’s US patent no 7,732,488, US patent no. 7,678,930 and US patent no. 7,718,698.
The patents entitled, ‘Pharmaceutical Composition Comprising Low Concentrations of Environmental Pollutants,’ ‘Process for Decreasing the Amount of Cholesterol in a Marine Oil Using a Volatile Working Fluid,’ and Process for Decreasing Environmental Pollutants in an Oil or a Fat.
Currently, Pronova BioPharma is involved in lawsuits with Teva in connection with the violation of its US patents nos. 5,502,077 ( ‘077 Patent) and 5,656,667 (‘667 Patent) related to Lovaza.